BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2352373)

  • 1. [PET assessment of myocardial viability with glucose loading and fasting FDG images].
    Niwayama H; Yoshida K; Kagaya A; Himi T; Masuda Y; Inagaki Y; Ito Y; Uematsu S; Imazeki K; Arimizu N
    Kaku Igaku; 1990 Mar; 27(3):285-8. PubMed ID: 2352373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple quantification of regional myocardial uptake of fluorine-18-deoxyglucose in the fasting condition.
    Tamaki N; Yonekura Y; Kawamoto M; Magata Y; Sasayama S; Takahashi N; Nohara R; Kambara H; Kawai C; Konishi J
    J Nucl Med; 1991 Nov; 32(11):2152-7. PubMed ID: 1941154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans.
    Choi Y; Brunken RC; Hawkins RA; Huang SC; Buxton DB; Hoh CK; Phelps ME; Schelbert HR
    Eur J Nucl Med; 1993 Apr; 20(4):308-18. PubMed ID: 8491223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quantitative evaluation of myocardial blood flow and myocardial fluoro-deoxyglucose uptake determined by PET before and after aorto-coronary bypass operation in patients with ischemic heart disease].
    Takahashi A; Iida H; Kanno I; Ono Y; Uemura K; Shishido F; Inugami A; Murakami M; Sato T; Abe Y
    Kaku Igaku; 1990 Mar; 27(3):227-35. PubMed ID: 2352367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between myocardial blood flow and fasting glucose metabolism in ischemic heart disease. Quantitative assessment by nitrogen-13 ammonia and fluorine-18 fluorodeoxyglucose positron emission tomography.
    Watanabe T; Okazaki O; Akutsu Y; Yamanaka H; Michihata T; Katagiri T; Harumi K
    Jpn Heart J; 1998 May; 39(3):275-85. PubMed ID: 9711179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of myocardial 18F-fluorodeoxyglucose positron emission computed tomography in dilated cardiomyopathy and ischemic cardiomyopathy.
    Yamaguchi H; Hasegawa S; Yoshioka J; Uehara T; Hashimoto K; Kusuoka H; Kuzuya T; Hori M; Nishimura T
    Ann Nucl Med; 2000 Feb; 14(1):33-8. PubMed ID: 10770578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans.
    Gropler RJ; Siegel BA; Lee KJ; Moerlein SM; Perry DJ; Bergmann SR; Geltman EM
    J Nucl Med; 1990 Nov; 31(11):1749-56. PubMed ID: 2230987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
    Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
    J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myocardial blood flow and glucose metabolism in patients with myocardial infarction evaluated by positron emission tomography: comparison with left ventriculography].
    Fudo T; Kambara H; Hashimoto T; Hayashi M; Kawai C; Senda M; Tamaki N; Yonekura Y
    J Cardiol; 1988 Mar; 18(1):13-20. PubMed ID: 3265437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism substrate with negative myocardial uptake of iodine-123-BMIPP.
    Kudoh T; Tamaki N; Magata Y; Konishi J; Nohara R; Iwasaki A; Ono S; Ohtake Y; Sugihara H; Sugihara H; Kuze K; Tsujimura Y; Miyazaki T
    J Nucl Med; 1997 Apr; 38(4):548-53. PubMed ID: 9098200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose.
    Gambhir SS; Schwaiger M; Huang SC; Krivokapich J; Schelbert HR; Nienaber CA; Phelps ME
    J Nucl Med; 1989 Mar; 30(3):359-66. PubMed ID: 2786939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET.
    Ohtake T; Yokoyama I; Watanabe T; Momose T; Serezawa T; Nishikawa J; Sasaki Y
    J Nucl Med; 1995 Mar; 36(3):456-63. PubMed ID: 7884509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography.
    Knuuti MJ; Nuutila P; Ruotsalainen U; Saraste M; Härkönen R; Ahonen A; Teräs M; Haaparanta M; Wegelius U; Haapanen A
    J Nucl Med; 1992 Jul; 33(7):1255-62. PubMed ID: 1613561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parametric images of myocardial metabolic rate of glucose generated from dynamic cardiac PET and 2-[18F]fluoro-2-deoxy-d-glucose studies.
    Choi Y; Hawkins RA; Huang SC; Gambhir SS; Brunken RC; Phelps ME; Schelbert HR
    J Nucl Med; 1991 Apr; 32(4):733-8. PubMed ID: 2013815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the duration of fasting on myocardial fluorine-18-fluorodeoxyglucose positron emission tomography images in normal males.
    Yamanouchi M; Yoshida K; Niwayama H; Nakagawa K; Aioi S; Shikama N; Himi T; Imazeki K; Itoh Y; Masuda Y
    Jpn Circ J; 1996 Jun; 60(6):319-27. PubMed ID: 8844297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simplified PET quantitation of myocardial glucose utilization.
    Nakagawa K; Namba H; Iyo M; Fukushi K; Irie T; Yamanouchi M; Shikama N; Himi T; Yoshida K; Masuda Y
    J Nucl Med; 1995 Nov; 36(11):2094-102. PubMed ID: 7472605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Appropriate uptake period for myocardial PET imaging with 18F-FDG after oral glucose loading].
    Brink I; Nitzsche EU; Mix M; Schindler T; Hentschel M; Högerle S; Moser E
    Nuklearmedizin; 2003 Feb; 42(1):39-44. PubMed ID: 12601453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thallium-201 reinjection images can identify the viable and necrotic myocardium similarly to metabolic imaging with glucose loading 18F-fluorodeoxyglucose (18FDG)-PET.
    Ogiu N; Nakai K; Hiramori K
    Ann Nucl Med; 1994 Aug; 8(3):171-6. PubMed ID: 7811558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Assessing myocardial viability in chronic myocardial infarct with 18F-fluoro-D-glucose positron emission tomography and 99mTc-MIBI SPECT].
    Schneider CA; Voth E; Theissen P; Wienhard K; Wagner R; Baer FM; Sechtem U; Schicha H
    Z Kardiol; 1994 Feb; 83(2):124-31. PubMed ID: 8165842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of quantitative analysis of glucose utilization in detection of myocardial viability by PET.
    Knuuti MJ; Nuutila P; Ruotsalainen U; Teräs M; Saraste M; Härkönen R; Ahonen A; Wegelius U; Haapanen A; Bergman J
    J Nucl Med; 1993 Dec; 34(12):2068-75. PubMed ID: 8254389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.